January 18th 2023
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
January 4th 2023
October 6th 2022
Study Finds Most Women With HIV Prefer LAI Antiretroviral Therapy Over Daily PillApril 30th 2020
In-depth interviews from 59 women living with HIV revealed that many women preferred long-acting injectable antiretroviral therapy for its convenience, privacy, and perceived effectiveness.